Chronic pharyngitis — a persistent scratchy, dry, or uncomfortable throat that lingers for weeks or months — is one of the most common reasons people seek care. In the United States alone, sore-throat-related visits number in the millions each year. In Traditional Chinese Medicine (TCM) practice, herbal formulas are a long-standing option for this complaint.

So consider a striking number: 320. That is how many randomized controlled trials (RCTs) of Chinese herbal medicine for chronic pharyngitis a research team recently gathered and examined. Three hundred and twenty trials sounds like an enormous body of evidence. Surely, with that many studies, we must know by now whether these treatments work?

A scoping review published in *Frontiers in Pharmacology* in October 2026 gives an uncomfortable answer: not really. Not because the trials were all poorly done, but because they measured such different things that their results cannot be meaningfully combined. This article explains what the review found — and what it teaches us about reading medical evidence of any kind.

What the Review Did

The researchers searched eight databases — four international (PubMed, Web of Science, Embase, Cochrane) and four Chinese (CNKI, Wanfang, VIP, SinoMed) — for RCTs of Chinese herbal medicine for chronic pharyngitis, covering literature up to August 2026. They found 320 eligible trials.

Importantly, their goal was not to decide whether the treatments work. It was something more foundational: to map out what these trials actually measured. They extracted every outcome indicator reported across all 320 trials and counted 1,204 of them, grouped into seven domains.

The purpose of this mapping is practical. It lays the groundwork for a "core outcome set" (核心结局指标集 héxīn jiéjú zhǐbiāo jí) — an agreed minimum list of outcomes that future trials should all measure, so that results can finally be compared and pooled.

Problem 1: Everyone Measured Something Different

Here is the central problem. With 1,204 outcome indicators spread across 320 trials, most indicators appeared in only a small handful of studies. The trials were, in effect, speaking different languages.

Imagine 320 cooks each preparing "the same" dish but using different thermometers, different scales, and different definitions of "done." One trial might score throat pain on a 0–10 scale. Another might grade pharyngeal redness as observed by the doctor. A third might count the days until symptoms eased. A fourth might report a composite "total effective rate" — a metric common in Chinese trials that bundles several observations into a single percentage.

None of these is necessarily wrong on its own. But when you try to combine them — to ask "across all 320 trials, how well does this work?" — you end up adding apples, pears, and the occasional bicycle. Meta-analysis, the statistical technique for pooling trials, requires studies to measure the same thing in comparable ways. Here, for the most part, they did not.

Outcome heterogeneity is not unique to TCM research; it troubles many fields. But 1,204 indicators is an unusually vivid illustration of the scale of the problem.

Problem 2: What Matters Most Was Rarely Measured

Just as revealing is what the trials did not measure. The review found that the outcomes patients tend to care about most — quality of life, costs, and what happens after treatment stops — were rarely assessed.

Most trials focused on short-term symptom scores and clinician-observed signs: Is the throat less red? Is the pain score lower after two weeks? These matter, but they leave the bigger questions unanswered. Did people feel meaningfully better in daily life? Did the benefit last? Was it worth the cost and effort?

Long-term follow-up was uncommon. For a chronic condition — one defined by its persistence — measuring only the first two to four weeks is like reviewing a marathon after the first mile.

Problem 3: Safety Was Reported, but Vaguely

Sixty-nine of the 320 trials reported adverse events. That sounds responsible — until you look closer. The review found that not a single one of those 69 trials specified the time point at which adverse events were assessed.

This matters enormously. "No serious adverse events were observed" means something very different if patients were watched for two weeks versus six months. Without a defined observation window, safety claims float free of context. It is a bit like a restaurant advertising "no complaints" without mentioning whether it ever asked its customers.

To be clear, this does not mean the treatments are unsafe. It means the available evidence does not allow us to assess safety with confidence — precisely the kind of gap a core outcome set is designed to close.

What This Means — and Doesn't Mean

This is where discussions of TCM research often go off the rails in both directions, so let us be careful.

What this review does not show:

  • - It does not show that Chinese herbal medicine does not work for chronic pharyngitis. The review was not designed to answer that question.
  • - It does not show that the 320 trials were worthless. Many may have been individually well-conducted; the problem lies at the level of the evidence base as a whole.

What it does show:

  • - We cannot currently give a confident, evidence-based answer to "how well does it work, for whom, and with what risks?" — not for lack of trials, but because the trials do not speak a common language.
  • - The fix is methodological, not ideological: agree on what to measure, measure it consistently, track harms properly, and follow patients for longer.

There is something optimistic in this. The researchers are not dismissing the field; they are building the infrastructure — the core outcome set — that would allow the next 320 trials to actually add up to something.

A Traditional Perspective on the Same Problem

Interestingly, the classical TCM framework contains its own version of this concern. In the traditional view, chronic throat discomfort is often discussed in terms of patterns (证 zhèng) — for example, yin deficiency with empty heat, or phlegm-dampness — rather than a single disease label. Two people carrying the same biomedical diagnosis of "chronic pharyngitis" might receive entirely different herbal formulas in TCM practice because their patterns differ.

This creates a genuine tension with the standard RCT model, which typically tests one fixed formula against a control. If the traditional logic holds that treatment should be individualized by pattern, then a trial of a single formula for all participants may not reflect how the medicine is actually practiced — one more reason the results are difficult to interpret.

Neither perspective cancels the other. Modern trial methodology asks, "does this specific intervention work on average?" The traditional framework asks, "what pattern is this person expressing, and what does it call for?" Both are legitimate questions; they simply require different study designs to answer well.

How to Read Trial Evidence: Three Quick Checks

The review offers a practical lesson for anyone reading health research — on TCM or anything else:

1. Check what was measured, not just the conclusion. A trial claiming effectiveness should tell you exactly which outcomes improved, by how much, and on what scale. 2. Check for how long. For chronic conditions, short follow-up is a warning sign. Benefits that fade after two weeks are a different matter from durable improvement. 3. Check how harms were tracked. Look for which adverse events were monitored, over what period, and in how many participants. Vague safety reporting deserves skepticism rather than reassurance.

These three checks take about five minutes and will substantially improve your ability to separate solid evidence from noise.

For everyday throat comfort — especially in dry autumn weather, when the classical framework associates throat dryness with the dryness pathogen (燥 zào) — simple measures such as staying hydrated and choosing moistening foods may help soothe the throat. Our guide to eating for autumn covers foods traditionally considered moistening, and our explainer on the six external pathogens describes how dryness is understood in the classical framework. A warm cup of tea is also a time-honored way to comfort an irritated throat — see our beginner's guide to Chinese tea culture.

The Bottom Line

Three hundred and twenty trials is a great deal of research. But research only becomes knowledge when studies can be compared — and comparison requires common measures, adequate follow-up, and honest safety reporting. The scoping review's greatest contribution may be making this invisible problem visible, and pointing toward the fix: a core outcome set around which future trials can converge.

Until then, the most honest answer to "does Chinese herbal medicine work for chronic pharyngitis?" remains: the evidence base is not yet organized enough to say with confidence. That is not a verdict on the medicine. It is a verdict on the measurements — and measurements can be fixed.

If you are interested in how the classical Chinese medical tradition thinks about health more broadly — its ideas of balance, prevention, and the body's patterns — our book *Huangdi Neijing: A Modern Introduction* ([INTERNAL:huangdi-neijing-modern-introduction]) offers a beginner-friendly guide to the foundational text of TCM.

*This article is for educational purposes only and is not medical advice. If you have persistent throat symptoms, please consult a qualified healthcare professional.*